'Potential Blockbuster' Dupixent Set For EU Eczema OK

 
• By Sten Stovall

While Dupixent looks set for use in Europe for treating moderate-to-severe atopic dermatitis, analysts believe the biologic has a great future in other indications and could eventually become a blockbuster.

Dermatitis
CHMP Has Backed Sanofi and Regeneron's Dupixent For Atopic Dermatitis • Source: Shutterstock

More from New Products

More from Scrip